Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Conklin MW, Gangnon RE, Sprague BL, Van Gemert L, Hampton JM, Eliceiri KW, Bredfeldt JS, Liu Y, Surachaicharn N, Newcomb PA, Friedl A, Keely PJ, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):138-145. doi: 10.1158/1055-9965.EPI-17-0720. Epub 2017 Nov 15.

PMID:
29141852
2.

Impact of Detection Method and Accompanying Ductal Carcinoma in Situ on Prognosis of T1a,bN0 Breast Cancer.

Shen SC, Ueng SH, Yang CK, Yu CC, Lo YF, Chang HK, Lin YC, Chen SC.

J Cancer. 2017 Jul 21;8(12):2328-2335. doi: 10.7150/jca.19293. eCollection 2017.

3.

Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.

Lo PK, Zhang Y, Yao Y, Wolfson B, Yu J, Han SY, Duru N, Zhou Q.

J Biol Chem. 2017 Jul 7;292(27):11466-11484. doi: 10.1074/jbc.M117.775080. Epub 2017 May 16.

PMID:
28512126
4.

Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.

Madubata CC, Liu Y, Goodman MS, Yun S, Yu J, Lian M, Colditz GA.

Breast Cancer Res Treat. 2016 Dec;160(3):563-572. doi: 10.1007/s10549-016-4030-6. Epub 2016 Oct 22.

5.

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

Elshof LE, Schaapveld M, Schmidt MK, Rutgers EJ, van Leeuwen FE, Wesseling J.

Breast Cancer Res Treat. 2016 Oct;159(3):553-63. doi: 10.1007/s10549-016-3973-y. Epub 2016 Sep 8. Erratum in: Breast Cancer Res Treat. 2017 Jan;161(2):389-390.

6.

How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Rahbar H, McDonald ES, Lee JM, Partridge SC, Lee CI.

Acad Radiol. 2016 Jun;23(6):768-73. doi: 10.1016/j.acra.2016.02.008. Epub 2016 Mar 23. Review.

7.

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.

Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, DeSantis S, Barry WT, Golshan M.

J Clin Oncol. 2016 Apr 10;34(11):1190-6. doi: 10.1200/JCO.2015.65.1869. Epub 2016 Feb 1.

8.

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.

Rakovitch E, Nofech-Mozes S, Hanna W, Baehner FL, Saskin R, Butler SM, Tuck A, Sengupta S, Elavathil L, Jani PA, Bonin M, Chang MC, Robertson SJ, Slodkowska E, Fong C, Anderson JM, Jamshidian F, Miller DP, Cherbavaz DB, Shak S, Paszat L.

Breast Cancer Res Treat. 2015 Jul;152(2):389-98. doi: 10.1007/s10549-015-3464-6. Epub 2015 Jun 29.

9.

Identifying women with dense breasts at high risk for interval cancer: a cohort study.

Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL; Breast Cancer Surveillance Consortium.

Ann Intern Med. 2015 May 19;162(10):673-81. doi: 10.7326/M14-1465.

10.

Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis.

Zhang X, Dai H, Liu B, Song F, Chen K.

Eur J Cancer Prev. 2016 Jan;25(1):19-28. doi: 10.1097/CEJ.0000000000000131.

11.

Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Van Cleef A, Altintas S, Huizing M, Papadimitriou K, Van Dam P, Tjalma W.

Facts Views Vis Obgyn. 2014;6(4):210-8. Review.

12.

Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state.

Boghaert E, Radisky DC, Nelson CM.

PLoS Comput Biol. 2014 Dec 4;10(12):e1003997. doi: 10.1371/journal.pcbi.1003997. eCollection 2014 Dec.

13.

Racial disparities in risk of second breast tumors after ductal carcinoma in situ.

Liu Y, Colditz GA, Gehlert S, Goodman M.

Breast Cancer Res Treat. 2014 Nov;148(1):163-73. doi: 10.1007/s10549-014-3151-z. Epub 2014 Sep 27.

14.

A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.

Narod SA, Rakovitch E.

Curr Oncol. 2014 Jun;21(3):119-24. doi: 10.3747/co.21.1892.

15.

Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.

Kong I, Narod SA, Taylor C, Paszat L, Saskin R, Nofech-Moses S, Thiruchelvam D, Hanna W, Pignol JP, Sengupta S, Elavathil L, Jani PA, Done SJ, Metcalfe S, Rakovitch E.

Curr Oncol. 2014 Feb;21(1):e96-e104. doi: 10.3747/co.21.1604.

16.

EZH2 expression in invasive lobular carcinoma of the breast.

Roh S, Park SY, Ko HS, Sohn JS, Cha EJ.

World J Surg Oncol. 2013 Nov 22;11:299. doi: 10.1186/1477-7819-11-299.

17.

The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer.

Witkiewicz AK, Cox DW, Rivadeneira D, Ertel AE, Fortina P, Schwartz GF, Knudsen ES.

Oncogene. 2014 Jul 24;33(30):3980-91. doi: 10.1038/onc.2013.367. Epub 2013 Oct 14.

18.

Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.

Parikh AR, Kaplan CP, Burke NJ, Livaudais-Toman J, Hwang ES, Karliner LS.

Breast Cancer Res Treat. 2013 Sep;141(2):261-8. doi: 10.1007/s10549-013-2676-x. Epub 2013 Sep 1.

19.

Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.

Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL; Breast Cancer Surveillance Consortium.

J Gen Intern Med. 2013 Nov;28(11):1454-62. doi: 10.1007/s11606-013-2507-0. Epub 2013 Jun 13.

20.

Intra-operative radiological margins assessment in conservative treatment for non-palpable DCIS: correlation to pathological examination and re-excision rate.

Buggi F, Mingozzi M, Curcio A, Rossi C, Nanni O, Bedei L, Sanna PA, Veltri S, Folli S.

Springerplus. 2013 May 24;2(1):243. doi: 10.1186/2193-1801-2-243. Print 2013 Dec.

Supplemental Content

Support Center